Lawmakers and military groups are stepping up the pressure on TRICARE to reverse its noncoverage policies for many molecular diagnostic tests. More than 50 U.S. senators and representatives signed on to a Feb. 27 letter to Chuck Hagel, secretary of defense, expressing concerns regarding TriCare’s change in reimbursement policy. The letter notes that on Jan….

This content is for Paid Members only.
Login Register